Jingrong Jean Cui
Chief Scientific Officer, Turning Point Therapeutics, Inc.
Companies
- BlossomHill Therapeutics, Inc.Board member Aug 6, 2026 to now1
- BlossomHill Therapeutics, Inc.Chief executive officer Aug 6, 2026 to now1
- BlossomHill Therapeutics, Inc.President Aug 6, 2026 to now1
- Turning Point Therapeutics, Inc.Board member Apr 16, 2019 to Jun 10, 20202
- Turning Point Therapeutics, Inc.Chief Scientific Officer Apr 16, 2019 to Jan 29, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- BlossomHill Therapeutics, Inc. BLSM2,134,242 shares3$29.1M at $13.62Aug 10, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 10, 2026Converted 124,779 shares of BlossomHill Therapeutics, Inc.3
- Aug 10, 2026Converted 113,435 shares of BlossomHill Therapeutics, Inc.3
- Aug 10, 2026Converted 1,600,682 shares of BlossomHill Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3